CT38
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CT38, covering 2020-04-30 to 2020-04-30. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome [Phase 1, Phase 2]